{"name":"Turn Therapeutics","slug":"turn-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNNmVkdS1YcFlpd3d5RDkzWVB2TXJLWlNfODN0TFlyZ25JSmhRTmN0c1BvT1RXUkMwWGx3RVBWbnpQN2lrc2duc1E4TnZpMEI4QjZYRzJmU2FHRzdmdm9CQmhvT2psUllhRXIwM283QWxFcklZc1g0b2UzcFdZd0VINlBrbm1IOG9JcEpKbTRxbGw3V3Z6SDlfaTZaZ2gwdHJ1ZXZaYURrUkdBUQ?oc=5","date":"2026-04-01","type":"pipeline","source":"Yahoo Finance","summary":"Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength? - Yahoo Finance","headline":"Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQQWZpb2hJZ3VQM0doY08taFRFNTM3TDN2OXRrSWFiTVlFUU03OHNKbEloOUhIcTh0SXp5LWtwS09sQnRCbE5vSE85WElJTUlIeWZrU3ZoWjRsbWQ5RUNTMzRzcUMyWldjdnVJVkU1Z093Z05PdUtFZkU1YUlwdlVxX1BTS0pOWUwxTUlRMUd4WEhDZ2ZUY1Z1VnhpMGIzQ2dud1HSAacBQVVfeXFMTTA3VndQZWRkSHB4elRHVldoUDFiLW9FdWxPejBHZExOaFZ5ZWZXeDhpX1pqSmR0dlhiSFQ4N19vOVVmVXl6eURLelNfVkJEaERHUlRicnQ4LWF6Nm43ZUlOU0N6Y3VqV0EzaGlOS21MdEE5UTd1aWVucUxkRnpxZndWZHNWVGFiQUM2c29XMkk0WlV3OENQcHZSN3FpV2I4bGlZNlBKckU?oc=5","date":"2026-03-25","type":"deal","source":"CNBC","summary":"Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC","headline":"Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-24","type":"pipeline","source":"The Economic Times","summary":"Glenmark Pharma may outperform amid market correction; technicals turn positive: Ruchit Jain - The Economic Times","headline":"Glenmark Pharma may outperform amid market correction; technicals turn positive: Ruchit Jain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE85VFJhcmVaQV82S0RuZDJySFBmcjJ4am5GRGNHSUdyeV8yZGRRYTFFbklNLUdselRSSnhXRWJUbGNSWUhKXzQ0RXBQUGVVTnkwUG1j?oc=5","date":"2026-03-05","type":"pipeline","source":"FirstWord Pharma","summary":"Daiichi turns to digital therapy for cholesterol care - FirstWord Pharma","headline":"Daiichi turns to digital therapy for cholesterol care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQam1fLXBxMVZWY1lTM2xncGdCREQxUlNRMmxoNkJZSlRHOXdtbEE0MXdXV1Z2SWstbnJwdnNNdzhSbWhLSzB5dDFNWG92cDVqRWVxWWxscEdzNnZjU2dLTUV3Uy1Gb0VmVXBTSDVjY3Y5X2JvaXUyRm5PTUctMGdhQUJ5ZHd3WE9lNE14cVN5UXdNLVVU?oc=5","date":"2026-03-02","type":"deal","source":"Yahoo Finance","summary":"A Look At BioCryst Pharmaceuticals (BCRX) Valuation As Net Income Turns Positive And Astria Deal Expands HAE Portfolio - Yahoo Finance","headline":"A Look At BioCryst Pharmaceuticals (BCRX) Valuation As Net Income Turns Positive And Astria Deal Expands HAE Portfolio","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-28","type":"earnings","source":"simplywall.st","summary":"ANI Pharmaceuticals (ANIP) Profitability Turn In Q4 2025 Tests Premium P/E Narrative - simplywall.st","headline":"ANI Pharmaceuticals (ANIP) Profitability Turn In Q4 2025 Tests Premium P/E Narrative","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNU2wxUzVrajVxaVFjLVpHS0ZLLXVadHluVUgwaVY2dTJETnc5M1pFbzJsRG1hd1JScnNaam5LT25rWGNNTkFabGVrNFFnU1Z4VkYzT2kwTGpOaW9neEFrS1k4NGV5RmNlX2d1VURMM2p5ZVJTVlc2TTRDeERsV1ZNVGlqeWdoOHNFN256bEFZakw2OVdEVHVZQnRkMDZydDkxMXRNOC1KQ1lCUjJQeDNwNVZxV1QzbE5N?oc=5","date":"2026-02-27","type":"earnings","source":"Benzinga","summary":"ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% - Benzinga","headline":"ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50%","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPT05KbHgxaThtSFI3VFBFTVV0OEpIZ1pfTUpnZzczNEFHZTdVTTV1VXFiRS1OaDhETjFlSktiOGREMVBESjc3VFBuTl9TMkhJUm42WmhXakZwZ3ZzNlViVmtuRHd3N3Z5ZzZBWHBUSjFyekZfT1VmRDJvY3dRZzBISDFXMnNfMms1ZnhKcy1xWXBjNmdENmFzUzJLcnJBU0pwRUw3UW11cWZLRzBqVWtxT2hkaE9MQ3ExSlpIMXZB?oc=5","date":"2025-10-28","type":"pipeline","source":"Pharmaceutical Technology","summary":"Turning bottlenecks into breakthroughs in gene therapy manufacturing - Pharmaceutical Technology","headline":"Turning bottlenecks into breakthroughs in gene therapy manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPYzltLVY4elNURGhMSmpRYzFybzNEcTRUNktHS3ZrZWhneGtiell1cjlfalJMZEk2QVRweXZ5enFYUGxuQTdFWkNtelZicFVWaERUeHJ2cTdrWUczZ1Q4bF9jMFVOUXBySi01MW9xcUJDVWJCNE15ME91N0Zyc0ktY2xURkJ4dHdNQ2dkVXlwUktiNk5WS2w4SUVlcGZWeU9DWXNCYUdIQXpsYmRfb2VERE11U1dFaGVwY2pzNzY4QTg1cHVSSFJDMG8zcFQ?oc=5","date":"2025-10-01","type":"deal","source":"Contract Pharma","summary":"Klotho Neurosciences to Acquire Longevity Therapeutic Assets from Turn Biotechnologies - Contract Pharma","headline":"Klotho Neurosciences to Acquire Longevity Therapeutic Assets from Turn Biotechnologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxQMS1TSm1fWnJ2OHVKZzN0OHJsQVpIYWhCRGZFd0N1cnFfUWMzRjhwcUgtempLRUVfb1VYcTktNkdzTFpNUkJ3RzJPV09kaDBIekpHUzRBYUtZLTdYRlo3Rkp0RnhNS3l3cjFRdXYwUmFKQzhHVlc0OEZFa1Y5LTR4NzhtUDZnWmNwWFZTbTdxSUdfcUtrOEdWbWU0RWk1UUo3Wi12clU5X2lfSkx6UExveTVWUk5WZmtTSjhZMEFJWVppREhYZklNQk9BSzNvZHE5UzI4LTBjT28tbVRxTU1wdDNsbjQzTW9KamVNcmxVeG5qc0tncFIxV1lGZ1lFTlF4aWU0UGpGTFROdEJmVDZkem9Ba01taWFtWmRwRkM4Z20xRTlWMUJv?oc=5","date":"2025-09-30","type":"deal","source":"PR Newswire","summary":"Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership - PR Newswire","headline":"Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1JUzh1ZUc0QVA1MUU0ZVE5cTJqSU03M08tRDdtZHNjVGVpT1E5NHVrclpTS0o5S3NHeWVhNjdsQTEzUEk1YVNtZUMwT3dEbzQ3N2dUY3NFRTl2VXV3R1RPN3VjRWFndXQwQklZRklQVExWWnN3a3RVdVFpSQ?oc=5","date":"2025-08-28","type":"pipeline","source":"SpaceNews","summary":"How microgravity could transform pharmaceuticals - SpaceNews","headline":"How microgravity could transform pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPa1FheTdOUG5kWGFoeExXeGFyd2o5VjBkSFYtRGZxRTJwQjhkSFZyRGE4ZlVyN19kTy0yV2Znb3VOal90Uk01RkpJQnB3dnEzaTdqRGdvSERjd0QxWUoyUzN5OUJMaEpqRDBSYnVWRkVaWG9xMFU5NGJLNWhOdlF3eWpnek5kemNJTEF1SGpmSThncjBHOWYyb2hFZjAxWlFvRUlsVXRzU2VnTEJsbnpXU09lWkxHOFlDcUxyZ1FHSnV5Wmx1dmFuc2s5T3RvVGtZUHA3MHFZM3pXVHd1?oc=5","date":"2025-08-13","type":"pipeline","source":"Reuters","summary":"China pharma firms turn to local reagent suppliers to cut costs and delivery times - Reuters","headline":"China pharma firms turn to local reagent suppliers to cut costs and delivery times","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}